Results 51 to 60 of about 32,215 (290)

Heat shock protein expression and neoangiogenesis in salivary gland neoplasms

open access: yes, 2013
IntroductionSalivary gland neoplasms comprise a wide group of tumors with diverse histology and broad biologic behavior, often presenting difficulties in their definitive diagnosis and treatment. In the last decades, the prominent role of angiogenesis in
Papanikolaou, Vasileios   +1 more
core   +1 more source

Targeting Post‐Irradiation Thyroid Dysfunction: Electrospun Scaffolds As A Dual‐Action Approach for Antioxidant and Immune Modulation

open access: yesAdvanced Healthcare Materials, EarlyView.
Radiation‐induced hypothyroidism follows head and neck radiotherapy due to oxidative stress and inflammation. Electrospun polycaprolactone scaffolds containing adenosine have potential to modulate thyroid repair. Scaffolds enhance thyrocyte proliferation, antioxidant enzymes glutathione peroxidase and catalase, reduce senescence and apoptosis markers ...
Maria Heim   +5 more
wiley   +1 more source

Salivary gland cancer — epidemiology

open access: yes, 2018
Salivary gland tumors represent 3–11% of all head and neck cancers and 0.2% of all neoplasms. Among Poles, mali­gnancies involving the large salivary glands constituted 0.3% of all malignancies in Poland and 9.7% of head and neck neoplasms.
Kordzińska-Cisek, Izabela   +1 more
core   +1 more source

Thermally Modulated Metasurface Sensor for Dynamic and Time‐Resolved Isolation of Extracellular Vesicles

open access: yesAdvanced Materials, EarlyView.
A thermally adaptive plasmonic metasurface, functionalized with poly(N‐isopropylacrylamide) (PNIPAM) and anti‐CD63 antibodies, enables precise, on‐demand capture and release of extracellular vesicles (EVs). Delivering high recovery, improved purity, and intact vesicle structure, the platform offers a versatile, label‐free solution for real‐time EV ...
Beyza Nur Kucuk   +7 more
wiley   +1 more source

Salivary gland neoplasms: A Salivary gland neoplasms: A clinicopathological study of 84 cases

open access: yes, 2020
Background: Accounting for less than 2% of all human neoplasms, s relatively uncommon and it comprises a morphologically diverse group of rare tumors. FNAC has been employed in pre-operative diagnosis of salivary gland tumor as essential diagnostic tool ...
Junu Devi
core  

Clear cell odontogenic carcinoma versus hyalinizing clear cell carcinoma: A diagnostic dilemma

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2014
Clear cell neoplasms have created a considerable dilemma in the diagnosis of head and neck pathology. Clear cells may be seen in a variety of odontogenic neoplasms, salivary gland neoplasms, and metastatic tumors to the jaws, specifically renal cell ...
Rama Raju Devaraju   +3 more
doaj   +1 more source

The Development and Pilot Clinical Study of CD147 Targeted Antagonistic Peptide Probe for Tumor Imaging

open access: yesAdvanced Science, EarlyView.
This study establishes [68Ga]Ga‐DOTA‐AP9 as a first‐in‐human CD147‐targeted PET tracer with favorable safety and specific tumor uptake. Tracer accumulation correlates with CD147 expression in patients, enabling noninvasive quantification of CD147‐positive malignancies.
Xiaokun Ma   +10 more
wiley   +1 more source

Salivary Gland Neoplasms: Application of RNA-sequencing and Surrogate Immunohistochemical Markers to Refine Classification

open access: yes, 2021
Salivary gland tumours are diagnostically challenging neoplasms. Molecular analysis is increasingly being employed in tumour diagnosis and classification.
Bubola, Justin
core  

Interface Wettability Transition‐Driven Drug Release and Dual‐Phase Functionalization in Implant Abutment

open access: yesAdvanced Science, EarlyView.
A temporally controlled drug release coating is developed for abutments using a superhydrophobic coating self‐assembled on mesoporous silica. This surface provides sequential functionality: initial contamination resistance through non‐wetting, followed by controlled drug release via wettability transition.
Zhongchao Wang   +8 more
wiley   +1 more source

Balancing Stealth and Targetability: cCPP‐ and PEG‐Modified Liposomes for the Targeted Delivery of Anti‐HER2 Nanobodies

open access: yesAdvanced Science, EarlyView.
This study addresses the rapid renal clearance of anti‐HER2 nanobodies by developing specialized liposomal carriers. It details the formulation of dual modified liposomes, demonstrating how PEGylation preserves structural integrity and cell‐penetrating peptides enhance cellular interaction.
Giulia Pander   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy